Skip to main content
TipRanks
Go Ultimate75% OFF

Align Tech (ALGN) AI Stock Analysis

3,367 Followers
ALGN

Align Tech

(NASDAQ:ALGN)

Select Model
Rating:73Outperform
Price Target:$178.00â–²(8.56% Upside)
Action:reiterated
Date:11/06/26

ALGN scores well primarily due to strong underlying financial quality (especially the balance sheet) and a generally upbeat earnings outlook that emphasizes continued growth and margin expansion. Offsetting factors are a mixed technical picture (long-term trend still below major moving averages) and a valuation that is not especially compelling given the ~23x P/E and no dividend yield.

Positive Factors
Conservative balance sheetMinimal leverage gives Align substantial financial flexibility to fund innovation, withstand demand variability, and support commercial investment without depending heavily on borrowing. Its growing equity base further strengthens resilience and preserves options for long-term capital allocation.
Negative Factors
Clear aligner ASP pressureFalling revenue per case can limit sales growth even when shipment volumes increase, particularly as geographic and product mix shifts toward lower-priced offerings. Continued discounts and mix pressure could constrain revenue quality and make margin expansion harder to sustain.

Align Tech Key Performance Indicators (KPIs)

Revenue by SegmentShows how much revenue each business segment generates, highlighting which areas are driving growth and which may need strategic adjustments.

$0.00$250.00M$500.00M$750.00M$1.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Clear Aligner is the durable growth engine — recovering from the 2022 dip and accelerating through 2025–mid‑2026, signaling resilient case volume/ pricing rather than a one‑off lift. Imaging Systems & CAD/CAM are much smaller and lumpy, driven by device cycles and capex; recent weakness there while aligner revenue rises implies consumable/service demand is outpacing equipment sales. For investors, aligners lower revenue downside and underpin organic growth, but imaging cyclicality limits upside until scanner placements or enterprise deals re‑accelerate.

Data provided by:The Fly

Align Tech (ALGN) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%ALGN+15.01%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$11.52B
Dividend Yield
―
Average Volume (3M)
1.01M
Price to Earnings (P/E)
23.7
Beta (1Y)
1.18
Revenue Growth
4.42%
EPS Growth
33.43%
Country
US
Employees
20,290
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Align Tech Business Overview & Revenue Model

Company Description

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wid...

How the Company Makes Money

Align Technology primarily makes money by selling products and services that support clear aligner therapy and digital dentistry workflows. Its largest revenue stream is typically the Clear Aligner segment, where Align sells Invisalign clear aligner...

Align Tech Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:6.73%|Next Earnings Date:Feb 03, 2027
Earnings Call SentimentPositive

The call was positive overall. Align reported record Clear Aligner shipments and doctor submitters, broad international growth, improved utilization, stronger operating margins, healthy cash generation and continued investment in digital workflows and 3D-printing innovation. These strengths outweighed the lowlights, which included a challenging consumer environment, lower Systems and Services revenue, ASP and mix pressure, North American GP retail weakness, foreign exchange effects and reduced fourth-quarter revenue assumptions.

Positive Updates

Record Clear Aligner Shipments and Doctor Submitters
Third-quarter worldwide revenue was $1.015 billion, up 1.9% year-over-year or 2.4% at constant currency and in line with outlook. Clear Aligner shipments increased 6.6% to a record 691,000, at the high end of the expected mid-single-digit growth range. A record 91,000 doctors submitted Invisalign cases, up more than 3% year-over-year, while overall utilization increased 3.4%.

Negative Updates

Systems and Services Revenue Decline
Q3 Systems and Services revenue was $175.5 million, down 7.6% year-over-year or 7.1% at constant currency. Reported revenue reflected a greater mix of lower-priced scanner configurations and flexible acquisition models, including leasing, financing, rentals and certified preowned systems.

Company Guidance

For Q4 2026, assuming no circumstances occur beyond our control that could impact our business, Align expects worldwide revenues in the range of $1 billion to $1.020 billion, Clear Aligner volume to be up low single digits year-over-year, Clear Aligner ASP to be down approximately 1% year-over-year, Systems and Services revenue in the range of $170 million to $180 million, GAAP gross margin of approximately 71%, non-GAAP gross margin of approximately 72%, GAAP operating margin of approximately 20%, non-GAAP operating margin of approximately 26%, and to repurchase up to $300 million of common stock; for fiscal 2026, it expects worldwide revenue of approximately $4.11 billion to $4.13 billion, Clear Aligner volume and revenue growth up approximately 5% to 6% year-over-year, Clear Aligner ASP slightly below 2025, Systems and Services revenue of $715 million to $725 million, GAAP operating margin of approximately 16.2%, up approximately 2.7 points year-over-year, non-GAAP operating margin of approximately 23.7%, representing approximately 100 basis point improvement year-over-year, capital expenditures of approximately $125 million to $150 million, and approximately $500 million of common-stock repurchases; for 2027, Align expects another year of revenue growth and margin expansion, continued Invisalign volume growth, record doctor submitters, improving utilization, a broadly stable Clear Aligner pricing environment with ASP slightly down, Systems and Services revenue growth with solid unit growth and stable ASPs, and at least another 100 basis points of non-GAAP operating margin improvement, with preliminary planning assuming an operating environment broadly consistent with current conditions and not requiring a consumer recovery.

Align Tech Financial Statement Overview

Summary

Financials are solid overall, led by an exceptionally conservative balance sheet (very low leverage) and healthy profitability. Recent revenue growth has accelerated sharply, but margin compression versus the 2021 peak and some cash-flow conversion variability temper the score.

Income Statement

74Positive

Balance Sheet

90Very Positive

Cash Flow

71Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.16B4.03B4.00B3.86B3.73B3.95B
Gross Profit2.81B2.76B2.80B2.71B2.63B2.94B
EBITDA744.61M822.72M816.80M799.05M779.84M1.12B
Net Income491.87M410.35M421.36M445.05M361.57M772.02M
Balance Sheet
Total Assets6.52B6.23B6.21B6.08B5.95B5.94B
Cash, Cash Equivalents and Short-Term Investments1.14B1.09B1.04B972.74M999.58M1.17B
Total Debt146.46M114.45M119.28M126.62M126.91M125.38M
Total Liabilities2.22B2.18B2.36B2.45B2.35B2.32B
Stockholders Equity4.31B4.05B3.85B3.63B3.60B3.62B
Cash Flow
Free Cash Flow602.50M490.78M622.65M608.06M276.83M771.45M
Operating Cash Flow749.89M593.22M738.23M785.78M568.73M1.17B
Investing Cash Flow-296.71M-112.44M-254.91M-195.94M-213.32M-563.43M
Financing Cash Flow-307.90M-464.58M-355.72M-598.34M-501.69M-458.33M

Align Tech Technical Analysis

Technical Analysis SentimentNeutral
Last Price163.96

Price Trends

50DMA152.02Positive
100DMA161.45Positive
200DMA168.69Negative

Market Momentum

MACD4.81Negative
RSI54.86Neutral
STOCH48.40Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ALGN, the sentiment is Neutral. The current price of 163.96 is above the 20-day moving average (MA) of 160.21, above the 50-day MA of 152.02, and below the 200-day MA of 168.69, indicating a neutral trend. The MACD of 4.81 indicates Negative momentum. The RSI at 54.86 is Neutral, neither overbought nor oversold. The STOCH value of 48.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ALGN.

Align Tech Risk Analysis

Align Tech disclosed 37 risk factors in its most recent earnings report. Align Tech reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Our business could be negatively impacted as a result of shareholder activism.Q3, 2026
2.Our business could be negatively impacted as a result of shareholder activism.Q1, 2026
3.We are subject to various laws relating to privacy, data protection, data governance and cybersecurity, and face risks related to the data we collect, process, and share.Q4, 2025

Align Tech Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

ALGN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GEHCGEHC79Outperform$37.00B17.3619.85%0.18%6.87%-2.26%
ALGNALGN73Outperform$11.52B23.7211.76%―4.42%33.43%
INMDINMD69Neutral$743.47M10.4711.36%―2.50%-43.86%
PHGPHG67Neutral$29.02B26.958.44%3.31%――
VREXVREX57Neutral$768.59M34.544.60%―5.31%―
BFLYBFLY54Neutral$1.54B-27.72-28.22%―39.35%38.09%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%100%200%300%ALGNPHGVREXINMDBFLYGEHCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ALGN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ALGNAlign Technology163.9631.1523.45%
PHGKoninklijke Philips N.V.29.813.9515.28%
VREXVarex Imaging Corporation18.157.8676.38%
INMDInmode12.88-0.86-6.26%
BFLYButterfly Network, Inc.6.083.76162.07%
GEHCGe Healthcare Technologies Inc.83.669.0612.14%

Align Tech Corporate Events

Stock Buyback

Align Technology Announces $270 Million Share Repurchase Agreement

Positive
Nov 6, 2026

On November 5, 2026, Align Technology entered an accelerated share repurchase agreement with Goldman Sachs to repurchase $270 million of common stock under its $1.0 billion program approved in April 2025. Align announced the agreement on November 6,...

Business Operations and StrategyExecutive/Board Changes

Align Tech announces CEO succession and leadership transition

Positive
Oct 28, 2026

Align Technology announced on October 28, 2026, that its board has approved a CEO succession under which Jennifer L. Davis will join as CEO-elect and director on November 2, 2026, and become President and CEO on December 31, 2026. Davis, a veteran co...

Executive/Board Changes

Align Tech adds Quentin Blackford to board

Positive
Aug 31, 2026

On August 27, 2026, Align Technology’s board appointed Quentin Blackford, president and CEO of iRhythm Technologies, as a director, expanding the board from ten to eleven members and immediately adding a leader with deep experience in global healthca...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026